Acrylic Acid

Acrylic Acid

SCHEMBL1505076

C=CC(=O)O.CC(=O)Nc1ccccc1-c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
CYP2C9 P11712 2/20 0.58
HPGD P15428 2/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
LMNA P02545 1/20 0.51
THRB P10828 1/20 0.51
MAPT P10636 3/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
SOAT1 P35610 2/20 0.48
KDM4E B2RXH2 2/20 0.48
HTT P42858 2/20 0.48
KCNQ2 O43526 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL99181 0.90 ALDH1A1 (0.59) ALDH1A1CYP2C9HPGDMEN1KMT2A
Acrylic Acid SCHEMBL1505000 0.83 ALDH1A1 (0.57) ALDH1A1CYP2C9HPGDMEN1KMT2A
Propanol SCHEMBL28418591 0.82 SOAT1 (0.60) ALDH1A1CYP2C9HPGDMEN1KMT2A
SCHEMBL11600676 0.81 ALDH1A1 (0.68) ALDH1A1CYP2C9HPGDMEN1KMT2A
SCHEMBL9762630 0.79 ALDH1A1 (0.57) ALDH1A1CYP2C9HPGDMEN1KMT2A
SCHEMBL29035926 0.79 MEN1 (0.56) ALDH1A1CYP2C9HPGDMEN1KMT2A
SCHEMBL3640507 0.79 ALDH1A1 (0.50) ALDH1A1CYP2C9HPGDMEN1KMT2A
SCHEMBL6326388 0.78 ALDH1A1 (0.65) ALDH1A1CYP2C9HPGDMAPTCYP1A2
SCHEMBL21522574 0.78 ALDH1A1 (0.52) ALDH1A1CYP2C9HPGDMEN1KMT2A
SCHEMBL5213661 0.78 ALDH1A1 (0.56) ALDH1A1CYP2C9HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480523-B1 PROCESS FOR MANUFACTURE OF N-ACYLBPHENYL ALANINE ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2017-03-01 EP disclosed
US-20160115118-A1 PROCESS FOR THE MANUFACTURE OF N-ACYLBIPHENYL ALANINE ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2016-04-28 US disclosed
US-9242927-B2 Process for the manufacture of N-acylbiphenyl alanine ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD (CN) 2016-01-26 US disclosed
US-20140142320-A1 Process for the Manufacture of N-acylbiphenyl alanine ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2014-05-22 US disclosed
US-20130172572-A1 Process for Manufacture of N-acylbiphenyl alanine ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2013-07-04 US disclosed
EP-2480523-A1 PROCESS FOR MANUFACTURE OF N-ACYLBPHENYL ALANINE Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2012-08-01 EP disclosed
WO-2011035569-A1 PROCESS FOR MANUFACTURE OF N-ACYLBPHENYL ALANINE ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2011-03-31 WO disclosed
WO-2010034236-A1 PROCESS FOR THE MANUFACTURE OF N-ACYLBIPHENYL ALANINE ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160115118-A1 PROCESS FOR THE MANUFACTURE OF N-ACYLBIPHENYL ALANINE ANPEP, DNPEP, ENPEP ALDH1A1 1633/4885CYP2C9 667/4885HPGD 1134/4885
US-20140142320-A1 Process for the Manufacture of N-acylbiphenyl alanine ANPEP, DNPEP, ENPEP ALDH1A1 1633/4885CYP2C9 667/4885HPGD 1134/4885
US-20130172572-A1 Process for Manufacture of N-acylbiphenyl alanine ANPEP, DNPEP, RNPEP ALDH1A1 1757/4885CYP2C9 875/4885HPGD 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.